Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 3/10/2011 12:24:12 AM : Outperform Start Price: $9.94 LGND Score: +68.82

see this post.
http://caps.fool.com/Blogs/lgnd/536679.

Featured Broker Partners


Advertisement